The revenue forecast by P3 Health Partners for FY24 closely aligns with the current analyst estimates, suggesting a neutral impact on the stock price in the short term. The forecast falls within the expected range, indicating that the company's financial outlook is in line with market expectations, which typically does not lead to significant stock price movements unless accompanied by other, more surprising news or broader market shifts.